National shortage of GLP1 receptor agonist medication.

There is a national shortage of GLP1 receptor agonist medication (Victosa, Trulicity, Ozempic injections) which means there are interrupted supplies for patients, and limited alternative options.
We are doing everything we can, as quickly as possible, to source medications and address medication options with patients individually.
National guidance has been released to assist us in this situation and in making the best decisions for patient care.
Please continue to take the medication you have as prescribed, and we will be in touch in due course if this affects you.